Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 30.807 |
|
|||||
| News | - |
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| NRX Pharmaceuticals Inc | NRXPW | NASDAQ | Equity Warrant |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,0225 | -11,11% | 0,18 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 0,1999 | 0,16 | 0,200482 | 0,18 | 0,2025 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen |
|---|---|---|---|---|
| 136 | 30.807 | 0,1873155 | 5.771 | - |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 22:00:00 | 100 | 0,16 | USD |
Finanzwerte NRXPW
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 17,54M | 86,61M | - | 0 | -30,16M | -0,35 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News NRX Pharmaceuticals
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 22.1.2025 | 22:32 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.1.2025 | 22:12 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10.1.2025 | 14:32 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20.11.2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15.11.2024 | 23:24 | Edgar (US Regulatory) | Form 8-K - Current report |
| 14.11.2024 | 22:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 14.11.2024 | 18:21 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 31.10.2024 | 13:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15.10.2024 | 22:52 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11.10.2024 | 22:53 | Edgar (US Regulatory) | Form 8-K - Current report |
| 05.9.2024 | 22:18 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
| 23.5.2024 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum NRX Pharmaceuticals
Keine Diskussionen Gefunden.Neuen Thread Erstellen
NRXPW Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Monat | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 6 Monate | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 1 Jahr | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 3 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
| 5 Jahre | 0,00 | 0,00 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
NASDAQ:NRXPW -
What is the current NRX Pharmaceuticals Inc share price?
The current share price of NRX Pharmaceuticals Inc is US$ 0,18
How many NRX Pharmaceuticals Inc shares are in issue?
NRX Pharmaceuticals Inc has 86.608.000 shares in issue
What is the market cap of NRX Pharmaceuticals Inc?
The market capitalisation of NRX Pharmaceuticals Inc is USD 17,54M
What is the 1 year trading range for NRX Pharmaceuticals Inc share price?
NRX Pharmaceuticals Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of NRX Pharmaceuticals Inc?
The price to earnings ratio of NRX Pharmaceuticals Inc is -9,36
What is the reporting currency for NRX Pharmaceuticals Inc?
NRX Pharmaceuticals Inc reports financial results in USD
What is the latest annual profit for NRX Pharmaceuticals Inc?
The latest annual profit of NRX Pharmaceuticals Inc is USD -30,16M
What is the registered address of NRX Pharmaceuticals Inc?
The registered address for NRX Pharmaceuticals Inc is 1201 ORANGE ST, STE 600, ONE COMMERCE CENTER, WILMINGTON, DELAWARE, 19801
What is the NRX Pharmaceuticals Inc website address?
The website address for NRX Pharmaceuticals Inc is www.nrxpharma.com
Which industry sector does NRX Pharmaceuticals Inc operate in?
NRX Pharmaceuticals Inc operates in the BLANK CHECKS sector
